110 related articles for article (PubMed ID: 6162543)
21. Inhibition of thymidylate synthase by hydroxyurea in rapidly proliferating P815 mastocytoma cells.
Boehm TL; Kreis W; Drahovsky D
Biochim Biophys Acta; 1982 Jan; 696(1):52-6. PubMed ID: 6805512
[TBL] [Abstract][Full Text] [Related]
22. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
23. Perspective on the design and biochemical pharmacology of inhibitors of thymidylate synthetase.
Santi DV
J Med Chem; 1980 Feb; 23(2):103-11. PubMed ID: 6987403
[No Abstract] [Full Text] [Related]
24. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil.
Patel M; Ardalan K; Hochman I; Tian EM; Ardalan B
Anticancer Res; 2003; 23(1A):447-52. PubMed ID: 12680247
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of mammalian tumour thymidylate synthetase by 5-alkylated 2'-deoxyuridine 5'-phosphates.
Rode W; Kulikowski T; Kedzierska B; Jastreboff M; Shugar D
Biochem Pharmacol; 1984 Sep; 33(17):2699-705. PubMed ID: 6466380
[TBL] [Abstract][Full Text] [Related]
27. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth.
De Clercq E; Balzarini J; Torrence PF; Mertes MP; Schmidt CL; Shugar D; Barr PJ; Jones AS; Verhelst G; Walker RT
Mol Pharmacol; 1981 Mar; 19(2):321-30. PubMed ID: 7231392
[No Abstract] [Full Text] [Related]
28. Monitoring of the intracellular activation of 5-fluorouracil to deoxyribonucleotides in HT29 human colon cell line: application to modulation of metabolism and cytotoxicity study.
Ciccolini J; Peillard L; Aubert C; Formento P; Milano G; Catalin J
Fundam Clin Pharmacol; 2000; 14(2):147-54. PubMed ID: 10796062
[TBL] [Abstract][Full Text] [Related]
29. Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues.
Welsh SJ; Titley J; Brunton L; Valenti M; Monaghan P; Jackman AL; Aherne GW
Clin Cancer Res; 2000 Jun; 6(6):2538-46. PubMed ID: 10873110
[TBL] [Abstract][Full Text] [Related]
30. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
31. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
[TBL] [Abstract][Full Text] [Related]
32. The metabolic basis of deoxyuridine cytotoxicity. Studies of cultured human lymphoblasts.
Perez DJ; Tattersall MH
Mol Pharmacol; 1982 Jul; 22(1):166-74. PubMed ID: 6181385
[TBL] [Abstract][Full Text] [Related]
33. Thymidine labeling index of human breast carcinoma. Enhancement of in vitro labeling by 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
Meyer JS; Facher R
Cancer; 1977 Jun; 39(6):2524-32. PubMed ID: 141321
[TBL] [Abstract][Full Text] [Related]
34. Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture.
Laskin JD; Evans RM; Slocum HK; Burke D; Hakala MT
Cancer Res; 1979 Feb; 39(2 Pt 1):383-90. PubMed ID: 761209
[No Abstract] [Full Text] [Related]
35. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J
Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986
[TBL] [Abstract][Full Text] [Related]
36. 5(E)-(3-azidostyryl)-2'-deoxyuridine 5'-phosphate is a photoactivated inhibitor of thymidylate synthetase.
De Clercq E; Balzarini J; Chang CT; Bigge CF; Kalaritis P; Mertes MP
Biochem Biophys Res Commun; 1980 Dec; 97(3):1068-75. PubMed ID: 7470133
[No Abstract] [Full Text] [Related]
37. Clinical application of the concept of methotrexate plus 5-FU sequence-dependent "synergy": how good is the evidence?
Browman GP
Cancer Treat Rep; 1984 Mar; 68(3):465-9. PubMed ID: 6200218
[No Abstract] [Full Text] [Related]
38. Effects of 5-fluorouracil on various melanoma cell metabolisms. Its use for assessing the cold thymidine pool.
Vercammen-Grandjean AF; Arnould R; Libert A; Lejeune FJ
Anticancer Res; 1982; 2(3):133-40. PubMed ID: 7125600
[TBL] [Abstract][Full Text] [Related]
39. Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibition.
Block JB; Chlebowski RT; Dietrich MF; Isacoff WH
Cancer Treat Rep; 1984 Apr; 68(4):631-6. PubMed ID: 6538809
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
Ingraham HA; Tseng BY; Goulian M
Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
